Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration.

Yoichiro YoshidaAi MogiNaoya AisuTeppei YamadaTaisuke MatsuokaDaibo KojimaToshiyuki MeraTomoko KoganemaruFumiaki KiyomiKeita NodaYasushi TakamatsuKazuo TamuraYuichi YamashitaSuguru Hasegawa

Published in: SpringerPlus (2016)

A strong correlation was not observed between the results, and a weak correlation was observed between VAS and PV scores. Objective evaluation of oxaliplatin-induced vascular pain will be required to help patients overcome vascular pain.

Keyphrases

chronic pain
pain management
neuropathic pain
high glucose
end stage renal disease
diabetic rats
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
drug induced
endothelial cells
postoperative pain
patient reported outcomes
patient reported
chemotherapy induced